Dr. Grace Y. Lin, MD

Dr. Lin practices at Lambert Dialysis in Long Beach, California.

Dr. Lin's NPI, 1114167178, was assigned on March 3, 2009. Dr. Lin graduated from Feinberg School of Medicine in 2007. Dr. Lin holds California license A106746.

Dr. Lin's primary practice is Lambert Dialysis, at 3800 Kilroy Airport Way, Long Beach, CA 90806 in Los Angeles County. The practice phone is (562) 670-3921.

Dr. Lin's primary practice is Lambert Dialysis in Long Beach, California. Dr. Lin is also affiliated with PIH Health Whittier Hospital. The medical group on file is Pagiel Shechter, MD, Inc. Dmand AI also links Dr. Lin to 3 more hospitals, 3 dialysis centers, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 9 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Lin is board certified in internal medicine by the American Board of Internal Medicine. Dr. Lin is licensed in California.

Dmand AI lists acute kidney failure, chronic anemia, chronic kidney disease, electrolyte disorders, fluid and electrolyte imbalances, kidney failure and kidney stones among the conditions Dr. Lin treats.

CMS data shows 1,699 Medicare services from Dr. Lin across 7 procedure codes in 2024, for 374 Medicare patients. Medicare paid $114,696 for them.

CMS counts 374 Medicare patients who saw Dr. Lin in 2024. The largest group is 75 to 84, with 116 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 55% are also on Medicaid. Their average risk score is 4.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 72, with 50% women.

In 2024, Dr. Lin wrote 1,389 Medicare Part D claims for 304 patients. 76% of them were for generic drugs. CMS names the drug for 1,079 of them, across 36 drugs with 11 or more claims each, at $172,026 in total drug cost. In 2023, CMS named 927 claims across 30 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 11 papers to Dr. Lin, published from 2011 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Gene Expression Regulation, Transcription, Genetic and Brain. Dr. Lin's most frequent co-authors are Grace Y. Lin, MD, PhD, William Roger Auger, MD and Sudeep Banerjee.

CMS Open Payments shows 32 general payments to Dr. Lin from 16 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $346.

Dr. Lin graduated from Feinberg School of Medicine in 2007.

Dr. Lin is in network with 10 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.